TSC causes epilepsy in up to 85 % of patients, and up to 60 % of those patients do not respond to standard anti-seizure medicines
The company has also applied to DCGI for Emergency Use Authorization (EUA) for ZyCoVD, the world's first Plasmid DNA Vaccine
A total of 526 brands has seen a reduction of up to 90 per cent in MRP
This robust performance is a testimony of the company's agility, resilience and strong execution capabilities during these difficult times
A globally approved pen filled by mass technology provides a safer self- administration fertility solution
Nearly 6,000 patients have been treated with the drug since 2017
Company working on COVID vaccine INO 4800
The product can be used by any lab that conducts NGS testing, making precision medicine accessible to all cancer patients
Single booster dose at 6 months of NVX-CoV2373 increased wild-type neutralizing antibodies more than 4-fold versus primary vaccination series
By 2022, 150,000 primary health care centres would be in place in rural as well as urban areas
Subscribe To Our Newsletter & Stay Updated
